summary 1. A within-patient comparison showed that bethanidine. methyldopa and propranolol produced similar control of the blood pressure.
Introduction
&Adrenoreceptor-blocking drugs have been widely used in the treatment of hypertension (Simpson, 1974) . Studies have suggested that propranolol is of similar potency to bethanidine, guanethidine or methyldopa (hichard & Gillam, 1969; Zacharias, Cowen, Vickers & Wall, 1972) . To assess the efficacy of propranolol more formally we have made a prospective study closely following the design of Prichard, Johnston, Hill & Rosenheim (1968) .
Methods
Patients were seen under standardized clinic conditions at 2-weekly intervals, and received each of the three drugs in random order, presented in capsules of identical appearance of two sizes: bethanidine 10 mg and 30 mg, methyldopa 125 mg and 375 mg, and propranolol40 mg and 120 mg.
At each clinic visit patients were weighed and they then filled in a questionnaire, which included questions about their general state of well being and marking a 100 mm analogue line. Patients kept weekly record sheets on which they recorded any attacks of dizziness, headaches, bowel motions and the number of times urine was passed. Blood pressure was taken with the London School of Hygiene Sphygmomanometer (Rose, Holland & Crowley, 1964) , supine 1 min and 3 min, standing 1 min, at the end of twenty-four step-ups on a 21 cm step over 1 min and again 1 min postexercise by an observer physician unaware of the replies to the questionnaire or previous blood pressures. Patients then saw the assessor physician, who was aware of any side effects and the blood pressure readings. To facilitate rapid and safe dose adjustment this physician was 'nonblind'; moreover he would decode many patients' treatment because of characteristic side effects. The assessor physician followed the instructions of the observer physician as regards any alterations of dose as dictated by the blood pressure, unless side effects prevented such a course. Each drug was assessed over a period of seven visits to the clinic. The assessment period of 3 months commenced when diastolic blood pressure was controlled to a predetermined satisfactory level, generally 80-90 mmHg, standing. Before each assessment period there was a 'run-in' period during which dosage was stabilized and treatment changed from the previous drug. The first 'run-in' period also served to familiarize the patient with the trial procedure and stabilize the effect of increased physician interest. Moduretic [hydrochlorothiazide 0.168 mmol (50 mg) and amiloride 0.019 mmol (5 mg)], one tablet twice daily, was added when it was not possible to otherwise obtain satisfactory control of the blood pressure.
At the end of each assessment period patients 568s B. N. C. Prichd, A. J. Boakes and B. R. Graham filled in a questionnaire designed to elicit the side effects, and they were asked to assess the severity and frequency of side effects on a five point scale.
Investigations performed included simple lungfunction studies. Patients who had been receiving diuretics were then changed to placebo for up to four further visits, or less if the standing diastolic pressure rose above 110 mmHg.
Patients were informed that the study was designed to investigate the relative merit of the three drugs, that it was not the usual pattern of treatment, and their participation was invited. The study was approved by the hospital ethical committee.
Results

Patients
Seventeen patients (sixteen with essential and one with renal hypertension) completed the trial. Three patients were withdrawn for reasons unrelated to drug therapy. One patient had increasing breathlessness on propranolol ; the remainder completed all three drugs.
Drug dosage
Dosage of the drugs is as given in Table 1 . Mean values with SEM in parentheses are shown. Significance of differences: * P indicates significant difference from result with both of the other drugs; ** P indicates significant difference for pair of values shown. (a Includes one patient who did not tolerate propranolol.
Comparison of hypotensive drugs 569s
Moduretic was used in eleven patients with propranolol, in thirteen with bethanidine and in twelve with methyldopa. There was no correlation at all between the doses of propranolol and bethanidine (r = 0.199) or methyldopa (r = 0.030). The correlation between the doses of bethanidine and methyldopa did not quite reach the 5% level of significance (r = 0.436, t = 2.086).
Blood pressure control and effect of posture und exercise
The average blood pressures supine at 3 min, standing and immediately postexercise are given in Table 1 .
The response of the blood pressure to standing and exercise was different on propranolol from that with bethanidine and methyldopa ( Table 1 ) The difference between bethanidine and methyldopa was also significant (P < 0.001). The ratio of supine to 1 min postexercise pressures broadly showed the same pattern of difference between the drugs: for propranolol the ratio was 1.11 (0.14), methyldopa 1.02 (0.02) and for bethanidine 0.87 (0.03). The differences for propranolol and methyldopa were significant at the 0.2% level, and for the other differences at 0.1 %.
Effect of the diuretic
In ten patients on each of the drugs, readings were obtained with constant dosage while on Moduretic and then on placebo; the last pressures on each were compared. A marked additive effect was seen with Moduretic and propranolol, or methyldopa. were similar for each of the drugs ( Table 1 ) .
Recordings of dizziness, headaches, bowel motions and nocturia from the weekly record sheets also failed to show any significant difference. Scores were allocated to the battery of direct questions asked at the end of each 3 months: differences between the total scores were not significant. The average total number of side effects elicited in response to the direct questions is shown in the Table. Each side effect was ranked 1, 2 or 3 according to the relative incidence of that side effect on each of the drugs, the total marked score was similar for each of the drugs. Ranked scores for two individual side effects showed significant differences, dry mouth on methyldopa was more common than with bethanidine (P < 0-025) or propranolol (P < 0.02). There was also significantly less loss of sexual desire on propranolol than methyldopa (P < 0.05).
Propranolol produced a small but significant reduction in FVC compared with methyldopa, whereas FEVl.o on propranolol was significantly less than on the other two drugs. FEVl.o/FVC (%) was similar on all three drugs. No significant differences in weight were seen. There was a small reduction in serum creatinine with methyldopa.
Discussion
These studies confirm that propranolol is of similar potency to bethanidine and methyldopa, and the relative absence of postural and exercise hypotension on propranolol compared with methyldopa and bethanidine (Richard & Gillam, 1969; Richard, Gillam & Graham, 1970) . The use of diuretics with propranolol has long been advocated (Richard & Gillam, 1969; Zacharias et al., 1972) and we have provided further evidence for their additive effect with propranolol. The overall incidence of side effects on these three drugs were similar. We have recently discussed broader implications of therapy with these drugs (Richard & Tuckman, 1976) .
